PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
PATH vs. QCOM
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between PATH and QCOM is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.5

Performance

PATH vs. QCOM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in UiPath Inc. (PATH) and QUALCOMM Incorporated (QCOM). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%30.00%AugustSeptemberOctoberNovemberDecember2025
8.08%
-10.71%
PATH
QCOM

Key characteristics

Sharpe Ratio

PATH:

-0.75

QCOM:

0.53

Sortino Ratio

PATH:

-0.78

QCOM:

0.96

Omega Ratio

PATH:

0.88

QCOM:

1.12

Calmar Ratio

PATH:

-0.46

QCOM:

0.62

Martin Ratio

PATH:

-0.91

QCOM:

1.06

Ulcer Index

PATH:

43.78%

QCOM:

19.35%

Daily Std Dev

PATH:

53.03%

QCOM:

38.44%

Max Drawdown

PATH:

-87.61%

QCOM:

-86.75%

Current Drawdown

PATH:

-84.70%

QCOM:

-26.78%

Fundamentals

Market Cap

PATH:

$7.16B

QCOM:

$182.83B

EPS

PATH:

-$0.16

QCOM:

$8.94

PEG Ratio

PATH:

0.76

QCOM:

1.59

Total Revenue (TTM)

PATH:

$1.41B

QCOM:

$29.03B

Gross Profit (TTM)

PATH:

$1.17B

QCOM:

$16.28B

EBITDA (TTM)

PATH:

-$163.23M

QCOM:

$8.68B

Returns By Period

In the year-to-date period, PATH achieves a 2.44% return, which is significantly lower than QCOM's 7.12% return.


PATH

YTD

2.44%

1M

0.39%

6M

8.05%

1Y

-39.72%

5Y*

N/A

10Y*

N/A

QCOM

YTD

7.12%

1M

7.52%

6M

-10.71%

1Y

15.50%

5Y*

13.93%

10Y*

11.77%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

PATH vs. QCOM — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PATH
The Risk-Adjusted Performance Rank of PATH is 1616
Overall Rank
The Sharpe Ratio Rank of PATH is 1010
Sharpe Ratio Rank
The Sortino Ratio Rank of PATH is 1414
Sortino Ratio Rank
The Omega Ratio Rank of PATH is 1212
Omega Ratio Rank
The Calmar Ratio Rank of PATH is 1919
Calmar Ratio Rank
The Martin Ratio Rank of PATH is 2626
Martin Ratio Rank

QCOM
The Risk-Adjusted Performance Rank of QCOM is 6262
Overall Rank
The Sharpe Ratio Rank of QCOM is 6565
Sharpe Ratio Rank
The Sortino Ratio Rank of QCOM is 5858
Sortino Ratio Rank
The Omega Ratio Rank of QCOM is 5757
Omega Ratio Rank
The Calmar Ratio Rank of QCOM is 7171
Calmar Ratio Rank
The Martin Ratio Rank of QCOM is 5959
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

PATH vs. QCOM - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for UiPath Inc. (PATH) and QUALCOMM Incorporated (QCOM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for PATH, currently valued at -0.75, compared to the broader market-2.000.002.004.00-0.750.53
The chart of Sortino ratio for PATH, currently valued at -0.78, compared to the broader market-4.00-2.000.002.004.00-0.780.96
The chart of Omega ratio for PATH, currently valued at 0.88, compared to the broader market0.501.001.502.000.881.12
The chart of Calmar ratio for PATH, currently valued at -0.46, compared to the broader market0.002.004.006.00-0.460.62
The chart of Martin ratio for PATH, currently valued at -0.91, compared to the broader market-10.000.0010.0020.00-0.911.06
PATH
QCOM

The current PATH Sharpe Ratio is -0.75, which is lower than the QCOM Sharpe Ratio of 0.53. The chart below compares the historical Sharpe Ratios of PATH and QCOM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.00AugustSeptemberOctoberNovemberDecember2025
-0.75
0.53
PATH
QCOM

Dividends

PATH vs. QCOM - Dividend Comparison

PATH has not paid dividends to shareholders, while QCOM's dividend yield for the trailing twelve months is around 2.04%.


TTM20242023202220212020201920182017201620152014
PATH
UiPath Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
QCOM
QUALCOMM Incorporated
2.04%2.18%2.18%2.67%1.47%1.69%2.81%4.27%3.50%3.17%3.72%2.17%

Drawdowns

PATH vs. QCOM - Drawdown Comparison

The maximum PATH drawdown since its inception was -87.61%, roughly equal to the maximum QCOM drawdown of -86.75%. Use the drawdown chart below to compare losses from any high point for PATH and QCOM. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%AugustSeptemberOctoberNovemberDecember2025
-84.70%
-26.78%
PATH
QCOM

Volatility

PATH vs. QCOM - Volatility Comparison

UiPath Inc. (PATH) has a higher volatility of 12.80% compared to QUALCOMM Incorporated (QCOM) at 8.03%. This indicates that PATH's price experiences larger fluctuations and is considered to be riskier than QCOM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%AugustSeptemberOctoberNovemberDecember2025
12.80%
8.03%
PATH
QCOM

Financials

PATH vs. QCOM - Financials Comparison

This section allows you to compare key financial metrics between UiPath Inc. and QUALCOMM Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab